HERAMED LIMITED - Announcements

Market Cap $10.61M Add to my watchlist

Healthcare Medical Devices

Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for... Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) has confirmed its completion of the latest fast-infusion study using its R327 anti-infective as an IV drug.

Announcements

Filter Results

All Price Sensitive Only

HMD	Change of Company Secretary & Registered Address		02/03/20	86.09KB	Share
HMD	Appendix 4E & Preliminary Final Report	PRICE SENSITIVE	27/02/20	582.73KB	Share
HMD	Cleansing Notice		20/02/20	150.54KB	Share
HMD	Appendix 2A		19/02/20	281.96KB	Share
HMD	Proposed issue of Securities - HMD		19/02/20	28.45KB	Share
HMD	Results of General Meeting		19/02/20	145.02KB	Share
HMD	HeraBEAT Plus Clinical Trial Study Details		17/02/20	185.88KB	Share
HMD	Mayo Clinic clinical study to evaluate HeraBEAT Plus		10/02/20	126.15KB	Share
HMD	HeraMED appoints US General Manager of Operations	PRICE SENSITIVE	03/02/20	264.42KB	Share
HMD	December Quarter Activities Report and Appendix 4C	PRICE SENSITIVE	30/01/20	600.1KB	Share
HMD	Notice of Extraordinary General Meeting and Proxy Form		20/01/20	997.63KB	Share
HMD	HMD accesses unique pregnancy database to strengthen OrionAI	PRICE SENSITIVE	20/01/20	359.06KB	Share
HMD	Response to ASX Aware Query	PRICE SENSITIVE	20/01/20	372.32KB	Share
HMD	Update on Voluntary Escrow for Minor Vendor Options		09/01/20	126.59KB	Share
HMD	Cleansing Notice		17/12/19	152.3KB	Share
HMD	Appendix 3B		17/12/19	537.04KB	Share
HMD	Appendix 3B		12/12/19	528.83KB	Share
HMD	A$1.42m strategic placement completed to expedite US entry	PRICE SENSITIVE	10/12/19	145.16KB	Share
HMD	Trading Halt	PRICE SENSITIVE	06/12/19	433.11KB	Share
HMD	New CPT codes allow for potential reimbursement in USA		04/12/19	183.78KB	Share
HMD	2020 Company Outlook		02/12/19	9.62MB	Share
HMD	Change of Director's Interest Notice - Tal Slonim		28/11/19	170.79KB	Share
HMD	Change of Director's Interest Notice - David Groberman		28/11/19	171.51KB	Share
HMD	Appendix 3B and ASX Escrow Release		28/11/19	775.23KB	Share
HMD	Indian Hospital Group Cooperates with H-Cube and HeraMED	PRICE SENSITIVE	25/11/19	164.02KB	Share
HMD	Agreement adds telehealth services to Herabeat in Germany	PRICE SENSITIVE	21/11/19	271.54KB	Share
HMD	Release of Securities from ASX Escrow Restriction		20/11/19	219.32KB	Share
HMD	HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device	PRICE SENSITIVE	18/11/19	225.29KB	Share
HMD	Retraction of Statements - Next Tech Stock Article	PRICE SENSITIVE	15/11/19	159.09KB	Share
HMD	Trading Halt	PRICE SENSITIVE	15/11/19	436.24KB	Share
HMD	Pause in Trade	PRICE SENSITIVE	15/11/19	116.52KB	Share
HMD	Response to ASX Price and Volume Query	PRICE SENSITIVE	14/11/19	602.38KB	Share
HMD	Trading Halt	PRICE SENSITIVE	14/11/19	437.42KB	Share
HMD	Pause in Trading	PRICE SENSITIVE	14/11/19	116.15KB	Share
HMD	Hapvida Saude (Brazil) Trial Update		07/11/19	275.23KB	Share
HMD	Appendix 3B		05/11/19	531.66KB	Share
HMD	September Quarter Activities Report and Appendix 4C	PRICE SENSITIVE	30/10/19	446.91KB	Share
HMD	Market entry for HeraBEAT and HeraCARE Progresses in India	PRICE SENSITIVE	25/10/19	440.85KB	Share
HMD	HeraCARE - the digital era of pregnancy care		14/10/19	6.99MB	Share
HMD	Collaboration agreement secured with IntMED Software Ltd ME		02/10/19	215.65KB	Share
HMD	HMD passes first stage for Israel Innovation Authority Grant		24/09/19	445.25KB	Share
HMD	HeraMED and Mayo Clinic to co-develop a New Platform		17/09/19	726.36KB	Share
HMD	Global Distribution Progress Update		04/09/19	307.21KB	Share
HMD	Appendix 3B		28/08/19	493.71KB	Share
HMD	HeraMED Solutions Operational Across Multiple Hapvida Sites	PRICE SENSITIVE	28/08/19	324.43KB	Share
HMD	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/08/19	529.08KB	Share
HMD	Correction to Appendix 4C	PRICE SENSITIVE	14/08/19	401.48KB	Share
HMD	HeraMED enters the German market with initial PO secured	PRICE SENSITIVE	12/08/19	191.65KB	Share
HMD	June Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	31/07/19	356.29KB	Share
HMD	HeraCARE Investor Presentation July 2019		22/07/19	2.04MB	Share
HMD	HeraCARE PRO Integrated into Hapvidas Hospital Systems	PRICE SENSITIVE	01/07/19	333.13KB	Share
HMD	HeraBEAT Australian B2C launch underway	PRICE SENSITIVE	19/06/19	334.28KB	Share
HMD	Appendix 3B		14/06/19	488.81KB	Share
HMD	Appendix 3B		06/06/19	488.88KB	Share
HMD	Appendix 3B		03/06/19	489.96KB	Share
HMD	Release of Securities from Escrow		31/05/19	146.67KB	Share
HMD	Results of Annual General Meeting		29/05/19	143.73KB	Share
HMD	Annual General Meeting Venue Room Update		24/05/19	143.17KB	Share
HMD	Dr Friedman joins HeraMED advisory board		20/05/19	281.27KB	Share
HMD	HeraMED to launch HeraBEAT in Mexico	PRICE SENSITIVE	15/05/19	192.11KB	Share
HMD	Company Presentation May 2019		14/05/19	14.23MB	Share
HMD	Release of Securities from Escrow		09/05/19	144.87KB	Share
HMD	HeraMED Expands European Distribution Network Clarification	PRICE SENSITIVE	08/05/19	161.69KB	Share
HMD	HeraMED Expands European Distribution Network	PRICE SENSITIVE	08/05/19	199.31KB	Share
HMD	HeraMED begins FDA Approval Process for HeraBEAT	PRICE SENSITIVE	29/04/19	164.94KB	Share
HMD	Notice of Annual General Meeting and Proxy Form		26/04/19	974.91KB	Share
HMD	March Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	26/04/19	386.96KB	Share
HMD	Meerkats Partners for HeraBEATs Australian B2C Launch	PRICE SENSITIVE	16/04/19	171.18KB	Share
HMD	HeraMED launches HeraBEAT in the United Kingdom	PRICE SENSITIVE	11/04/19	167.03KB	Share
HMD	Response to ASX Query - Annual Report as at 31/12/18	PRICE SENSITIVE	08/04/19	453.33KB	Share
HMD	Addendum to Annual Report		05/04/19	170.8KB	Share
HMD	Appendix 4G		29/03/19	266.59KB	Share
HMD	Annual Report		29/03/19	898.21KB	Share
HMD	Orion Artificial Intelligence Presentation		26/03/19	2.01MB	Share
HMD	Dr Arturo Weschler MD Appointed to Lead Orion AI Operations		26/03/19	168.83KB	Share
HMD	Quasar Manufacturing Agreement to Deliver Scale & Efficiency	PRICE SENSITIVE	13/03/19	162.62KB	Share
HMD	Appendix 4E & Preliminary Final Report	PRICE SENSITIVE	28/02/19	541.15KB	Share
HMD	Major Brazilian Health Care Group Places Initial Pilot Order	PRICE SENSITIVE	14/02/19	175.67KB	Share
HMD	December Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	31/01/19	321.83KB	Share
HMD	Australian Distribution Agreement for 9000 HeraBEAT Units	PRICE SENSITIVE	14/01/19	135.81KB	Share
HMD	December Investor Presentation		19/12/18	3.08MB	Share
HMD	Becoming a substantial holder - Holley Pharmaceutical Group		19/12/18	287.12KB	Share
HMD	HeraMED Completes Over-Subscribed $6 Million IPO		12/12/18	162.65KB	Share
HMD	Becoming a substantial holder - Tal Slonim		11/12/18	68.13KB	Share
HMD	Becoming a substantial holder - David Groberman		11/12/18	73.17KB	Share
HMD	Initial Director's Interest Notice - Tal Slonim		11/12/18	161.35KB	Share
HMD	Initial Director's Interest Notice - Ronald Weinberger		11/12/18	151KB	Share
HMD	Initial Director's Interest Notice - Doron Birger		11/12/18	150.75KB	Share
HMD	Initial Director's Interest Notice - David Hinton		11/12/18	151.33KB	Share
HMD	Initial Director's Interest Notice - David Groberman		11/12/18	162.09KB	Share
HMD	Statement of Confirmations		10/12/18	130.38KB	Share
HMD	Updated Statement of Commitments		10/12/18	74.52KB	Share
HMD	Voluntary Escrow		10/12/18	115.26KB	Share
HMD	Restricted Securities		10/12/18	124.82KB	Share
HMD	Updated Pro Forma Statement of Financial Position		10/12/18	145.37KB	Share
HMD	Capital Structure		10/12/18	191.54KB	Share
HMD	Securities Trading Policy		10/12/18	192.27KB	Share
HMD	Hera Med Ltd. Half Yearly Accounts to 30 June 2018		10/12/18	799.65KB	Share
HMD	Hera Med Ltd. 2016 and 2017 Full Year Accounts		10/12/18	2.34MB	Share
HMD	Supplementary Prospectus		10/12/18	294.64KB	Share

HMD Change of Company Secretary & Registered Address
02/03/20		86.09KB	Share
HMD Appendix 4E & Preliminary Final Report
27/02/20	PRICE SENSITIVE	582.73KB	Share
HMD Cleansing Notice
20/02/20		150.54KB	Share
HMD Appendix 2A
19/02/20		281.96KB	Share
HMD Proposed issue of Securities - HMD
19/02/20		28.45KB	Share
HMD Results of General Meeting
19/02/20		145.02KB	Share
HMD HeraBEAT Plus Clinical Trial Study Details
17/02/20		185.88KB	Share
HMD Mayo Clinic clinical study to evaluate HeraBEAT Plus
10/02/20		126.15KB	Share
HMD HeraMED appoints US General Manager of Operations
03/02/20	PRICE SENSITIVE	264.42KB	Share
HMD December Quarter Activities Report and Appendix 4C
30/01/20	PRICE SENSITIVE	600.1KB	Share
HMD Notice of Extraordinary General Meeting and Proxy Form
20/01/20		997.63KB	Share
HMD HMD accesses unique pregnancy database to strengthen OrionAI
20/01/20	PRICE SENSITIVE	359.06KB	Share
HMD Response to ASX Aware Query
20/01/20	PRICE SENSITIVE	372.32KB	Share
HMD Update on Voluntary Escrow for Minor Vendor Options
09/01/20		126.59KB	Share
HMD Cleansing Notice
17/12/19		152.3KB	Share
HMD Appendix 3B
17/12/19		537.04KB	Share
HMD Appendix 3B
12/12/19		528.83KB	Share
HMD A$1.42m strategic placement completed to expedite US entry
10/12/19	PRICE SENSITIVE	145.16KB	Share
HMD Trading Halt
06/12/19	PRICE SENSITIVE	433.11KB	Share
HMD New CPT codes allow for potential reimbursement in USA
04/12/19		183.78KB	Share
HMD 2020 Company Outlook
02/12/19		9.62MB	Share
HMD Change of Director's Interest Notice - Tal Slonim
28/11/19		170.79KB	Share
HMD Change of Director's Interest Notice - David Groberman
28/11/19		171.51KB	Share
HMD Appendix 3B and ASX Escrow Release
28/11/19		775.23KB	Share
HMD Indian Hospital Group Cooperates with H-Cube and HeraMED
25/11/19	PRICE SENSITIVE	164.02KB	Share
HMD Agreement adds telehealth services to Herabeat in Germany
21/11/19	PRICE SENSITIVE	271.54KB	Share
HMD Release of Securities from ASX Escrow Restriction
20/11/19		219.32KB	Share
HMD HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device
18/11/19	PRICE SENSITIVE	225.29KB	Share
HMD Retraction of Statements - Next Tech Stock Article
15/11/19	PRICE SENSITIVE	159.09KB	Share
HMD Trading Halt
15/11/19	PRICE SENSITIVE	436.24KB	Share
HMD Pause in Trade
15/11/19	PRICE SENSITIVE	116.52KB	Share
HMD Response to ASX Price and Volume Query
14/11/19	PRICE SENSITIVE	602.38KB	Share
HMD Trading Halt
14/11/19	PRICE SENSITIVE	437.42KB	Share
HMD Pause in Trading
14/11/19	PRICE SENSITIVE	116.15KB	Share
HMD Hapvida Saude (Brazil) Trial Update
07/11/19		275.23KB	Share
HMD Appendix 3B
05/11/19		531.66KB	Share
HMD September Quarter Activities Report and Appendix 4C
30/10/19	PRICE SENSITIVE	446.91KB	Share
HMD Market entry for HeraBEAT and HeraCARE Progresses in India
25/10/19	PRICE SENSITIVE	440.85KB	Share
HMD HeraCARE - the digital era of pregnancy care
14/10/19		6.99MB	Share
HMD Collaboration agreement secured with IntMED Software Ltd ME
02/10/19		215.65KB	Share
HMD HMD passes first stage for Israel Innovation Authority Grant
24/09/19		445.25KB	Share
HMD HeraMED and Mayo Clinic to co-develop a New Platform
17/09/19		726.36KB	Share
HMD Global Distribution Progress Update
04/09/19		307.21KB	Share
HMD Appendix 3B
28/08/19		493.71KB	Share
HMD HeraMED Solutions Operational Across Multiple Hapvida Sites
28/08/19	PRICE SENSITIVE	324.43KB	Share
HMD Appendix 4D and Half Year Report
28/08/19	PRICE SENSITIVE	529.08KB	Share
HMD Correction to Appendix 4C
14/08/19	PRICE SENSITIVE	401.48KB	Share
HMD HeraMED enters the German market with initial PO secured
12/08/19	PRICE SENSITIVE	191.65KB	Share
HMD June Quarterly Activities Report & Appendix 4C
31/07/19	PRICE SENSITIVE	356.29KB	Share
HMD HeraCARE Investor Presentation July 2019
22/07/19		2.04MB	Share
HMD HeraCARE PRO Integrated into Hapvidas Hospital Systems
01/07/19	PRICE SENSITIVE	333.13KB	Share
HMD HeraBEAT Australian B2C launch underway
19/06/19	PRICE SENSITIVE	334.28KB	Share
HMD Appendix 3B
14/06/19		488.81KB	Share
HMD Appendix 3B
06/06/19		488.88KB	Share
HMD Appendix 3B
03/06/19		489.96KB	Share
HMD Release of Securities from Escrow
31/05/19		146.67KB	Share
HMD Results of Annual General Meeting
29/05/19		143.73KB	Share
HMD Annual General Meeting Venue Room Update
24/05/19		143.17KB	Share
HMD Dr Friedman joins HeraMED advisory board
20/05/19		281.27KB	Share
HMD HeraMED to launch HeraBEAT in Mexico
15/05/19	PRICE SENSITIVE	192.11KB	Share
HMD Company Presentation May 2019
14/05/19		14.23MB	Share
HMD Release of Securities from Escrow
09/05/19		144.87KB	Share
HMD HeraMED Expands European Distribution Network Clarification
08/05/19	PRICE SENSITIVE	161.69KB	Share
HMD HeraMED Expands European Distribution Network
08/05/19	PRICE SENSITIVE	199.31KB	Share
HMD HeraMED begins FDA Approval Process for HeraBEAT
29/04/19	PRICE SENSITIVE	164.94KB	Share
HMD Notice of Annual General Meeting and Proxy Form
26/04/19		974.91KB	Share
HMD March Quarterly Activity Report & Appendix 4C
26/04/19	PRICE SENSITIVE	386.96KB	Share
HMD Meerkats Partners for HeraBEATs Australian B2C Launch
16/04/19	PRICE SENSITIVE	171.18KB	Share
HMD HeraMED launches HeraBEAT in the United Kingdom
11/04/19	PRICE SENSITIVE	167.03KB	Share
HMD Response to ASX Query - Annual Report as at 31/12/18
08/04/19	PRICE SENSITIVE	453.33KB	Share
HMD Addendum to Annual Report
05/04/19		170.8KB	Share
HMD Appendix 4G
29/03/19		266.59KB	Share
HMD Annual Report
29/03/19		898.21KB	Share
HMD Orion Artificial Intelligence Presentation
26/03/19		2.01MB	Share
HMD Dr Arturo Weschler MD Appointed to Lead Orion AI Operations
26/03/19		168.83KB	Share
HMD Quasar Manufacturing Agreement to Deliver Scale & Efficiency
13/03/19	PRICE SENSITIVE	162.62KB	Share
HMD Appendix 4E & Preliminary Final Report
28/02/19	PRICE SENSITIVE	541.15KB	Share
HMD Major Brazilian Health Care Group Places Initial Pilot Order
14/02/19	PRICE SENSITIVE	175.67KB	Share
HMD December Quarterly Activity Report & Appendix 4C
31/01/19	PRICE SENSITIVE	321.83KB	Share
HMD Australian Distribution Agreement for 9000 HeraBEAT Units
14/01/19	PRICE SENSITIVE	135.81KB	Share
HMD December Investor Presentation
19/12/18		3.08MB	Share
HMD Becoming a substantial holder - Holley Pharmaceutical Group
19/12/18		287.12KB	Share
HMD HeraMED Completes Over-Subscribed $6 Million IPO
12/12/18		162.65KB	Share
HMD Becoming a substantial holder - Tal Slonim
11/12/18		68.13KB	Share
HMD Becoming a substantial holder - David Groberman
11/12/18		73.17KB	Share
HMD Initial Director's Interest Notice - Tal Slonim
11/12/18		161.35KB	Share
HMD Initial Director's Interest Notice - Ronald Weinberger
11/12/18		151KB	Share
HMD Initial Director's Interest Notice - Doron Birger
11/12/18		150.75KB	Share
HMD Initial Director's Interest Notice - David Hinton
11/12/18		151.33KB	Share
HMD Initial Director's Interest Notice - David Groberman
11/12/18		162.09KB	Share
HMD Statement of Confirmations
10/12/18		130.38KB	Share
HMD Updated Statement of Commitments
10/12/18		74.52KB	Share
HMD Voluntary Escrow
10/12/18		115.26KB	Share
HMD Restricted Securities
10/12/18		124.82KB	Share
HMD Updated Pro Forma Statement of Financial Position
10/12/18		145.37KB	Share
HMD Capital Structure
10/12/18		191.54KB	Share
HMD Securities Trading Policy
10/12/18		192.27KB	Share
HMD Hera Med Ltd. Half Yearly Accounts to 30 June 2018
10/12/18		799.65KB	Share
HMD Hera Med Ltd. 2016 and 2017 Full Year Accounts
10/12/18		2.34MB	Share
HMD Supplementary Prospectus
10/12/18		294.64KB	Share

REFRESH

First 2 3 4

(20min delay)
Last 2.7¢		Change 0.004(17.4%)		Mkt cap ! $10.61M

Open	High	Low	Value	Volume
2.4¢	2.9¢	2.4¢	$28.53K	1.049M

Buyers (Bids)

No.	Vol.	Price($)
1	89999	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	50000	1

View Market Depth

No.	Vol.	Price($)
1	89999	0.027
1	16169	0.025
4	3059245	0.023
1	250000	0.022
2	235000	0.021

Price($)	Vol.	No.
0.028	50000	1
0.030	73000	1
0.032	600000	1
0.038	40000	1
0.100	1000	1

Last trade - 16.10pm 20/06/2024 (20 minute delay)


Last 2.5¢		Change 0.004 ( 8.70 %)
Open	High	Low	Volume
2.4¢	2.9¢	2.4¢	324439
Last updated 13.37pm 20/06/2024 ?

HMD (ASX) Chart

HERAMED LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories